Three-Dimensional Structure of Holo 3A,20J3-Hydroxysteroid

Total Page:16

File Type:pdf, Size:1020Kb

Three-Dimensional Structure of Holo 3A,20J3-Hydroxysteroid Proc. Nati. Acad. Sci. USA Vol. 88, pp. 10064-10068, November 1991 Biochemistry Three-dimensional structure of holo 3a,20j3-hydroxysteroid dehydrogenase: A member of a short-chain dehydrogenase family (x-ray crystaflography/steroid-metabolizing enzyme/dinucleotide-linked oxldoreductase/sterold-protein interaction/sequence and folding homologies) DEBASHIS GHOSH*t, CHARLES M. WEEKS*, PAWEL GROCHULSKI*t, WILLIAM L. DUAX*, MARY ERMAN*, ROBERT L. RIMSAY§, AND J. C. ORR§ *Medical Foundation of Buffalo, 73 High Street, Buffalo, NY 14203; and Memorial University of Newfoundland, St. John's, Newfoundland, Canada AlB 3V6 Communicated by Herbert A. Hauptman, July 18, 1991 (receivedfor review May 14, 1991) ABSTRACT The x-ray structure of a short-chain dehy- the substrate binding regions, offers further insight concern- drogenase, the bacterial holo 3a,20/3-hydroxysteroid dehydro- ing the significance of conserved residues and their possible genase (EC 1.1.1.53), is described at 2.6 A resolution. This roles in substrate specificity and overall enzyme function. enzyme is active as a tetramer and crystallizes with four identical subunits in the asymmetric unit. It has the a/( fold characteristic ofthe dinucleotide binding region. The fold ofthe MATERIALS AND METHODS rest of the subunit, the quarternary structure, and the nature The crystals, grown in the presence of 4 mM NADH, belong ofthe cofactor-enzyme interactions are, however, significantly to the space group P43212 having unit cell dimensions a = different from those observed in the long-chain dehydrogena- 106.2 A and c = 203.8 A and contain one full tetramer (106 ses. The architecture of the postulated active site is consistent kDa) in the asymmetric unit (13). Native and HgCl2 and with the observed stereospecificity of the enzyme and the fact KAu(CN)2 derivative data sets were collected on a Mark III that the tetramer is the active form. There is only one cofactor multiwire area detector at the Research Resource in Protein and one substrate-binding site per subunit; the specificity for Crystallography, University of California at San Diego. The both 3a- and 2013-ends of the steroid results from the binding native data set had 91,203 observations for 20,738 unique of the steroid in two orientations near the same cofactor at the reflections to 3.0 A resolution with an Rmerg(I) of0.081. Two same catalytic site. Hg and one Au data sets contained 127,285 and 31,590 (Hg) and 94,437 (Au) observations for 32,843 and 15,909 (Hg) and 3a,20f3-Hydroxysteroid dehydrogenase [3a,20f3-HSD; (20R)- 29,666 (Au) reflections, respectively, including the Friedel 17a,20,21-trihydroxysteroid:NAD+ oxidoreductase, EC mates, to 3.3 A. The Rmerge(I) values were 0.109, 0.076, and 1.1.1.53] from Streptomyces hydrogenans is a nicotinamide 0.080, and the R(F)io values were 0.21, 0.17, and 0.11, adenine dinucleotide [NAD(H)]-linked enzyme involved in respectively (see ref. 14 for definition of terms). In addition, the reversible oxidation of the 3a- and 20f3-hydroxyl groups a 3.3 A data set having 29,039 observations and 10,709 unique of androstane and pregnane derivatives. Recent sequence reflections was also collected on a Hg + Au double derivative determination has revealed that 3a,20/3-HSD is a member of [R(fliso = 0.20]. A set of native data to 2.6 A, having 106,145 the nonmetallo-short-chain alcohol dehydrogenase (ADH) observations for 28,726 unique reflections [R.ee(I) = family (1), which includes 11f,-hydroxysteroid (llP-HSD) 0.091], was collected on film from six crystals at the Cornell (2), 7a-hydroxysteroid (3), and 15-hydroxyprostaglandin de- High Energy Synchrotron Source and processed by using hydrogenases (4) from mammals; glucose (5) and ribitol (6) Rossmann's program at Purdue University. The area detec- dehydrogenases, as well as a putative nodulation factor (7) tor data to 3 A and film data between 3 and 2.6 A were merged from bacteria; and an ADH (8) from insects. Enzymes into a composite native data set. The Hg derivatives each had belonging to this family have -250 amino acid residues, a single major binding site per subunit, whereas the Au similar coenzyme specificity, and partial sequence homol- reagent gave a "multiple low-occupancy site" derivative that ogy. Although more than 40 crystal structures of =15 types was used only to 4.5 A with marginal effect in phasing. The of NAD(H)- and NADP(H)-linked dehydrogenase enzymes double derivative had an additional Au site at a special have been determined at medium-to-high resolution (9), to position. Four Hg-binding positions were determined and our knowledge no x-ray crystallographic study describing the refined by programs HASSP and HEAVY (15), respectively three-dimensional structure of a dehydrogenase belonging to (with the Wilson plot scale factor, the occupancies at the four this short-chain class has been reported. This is only the third major sites were refined to 1.00, 1.02, 1.04, and 0.94). The structure ofan enzyme for which steroids are the substrate to choice of enantiomorph was determined from the anomalous be determined by x-ray diffraction techniques. A low- data. The final phasing powers for the Hg, the Au, and the resolution structure of keto-steroid isomerase (10) and the double derivatives were 2.43, 0.90, and 3.01, respectively, refined structure of cholesterol oxidase (11) have been pub- and the centric R values were 0.59, 0.75, and 0.54, respec- lished. tively. The overall figure-of-merit at 3.3 A was 0.61. To account for the ability of 3a,20f3-HSD to transfer a hydride to either end of a steroid molecule, "one steroid-two Abbreviations: HSD, hydroxysteroid dehydrogenase; MIR, multiple cofactor sites" and "two steroid orientations-one cofactor isomorphous replacement; GAPDH, glyceraldehyde-3-phosphate site" models (12) have been proposed. When analyzed in dehydrogenase; LDH, lactate dehydrogenase; MDH, malate dehy- conjunction with sequence homology studies, the three- drogenase; ADH, alcohol dehydrogenase. dimensional structured especially at the cofactor binding and ITo whom reprint requests should be addressed. *Permanent address: Technical University of Lodz, Institute of Physics, 93-005 Lodz, Poland. The publication costs of this article were defrayed in part by page charge IThe atomic coordinates and structure factors have been deposited payment. This article must therefore be hereby marked "advertisement" in the Protein Data Bank, Chemistry Department, Brookhaven in accordance with 18 U.S.C. §1734 solely to indicate this fact. National Laboratory, Upton, NY 11973 (reference 1 HSD). 10064 Downloaded by guest on September 28, 2021 Biochemistry: Ghosh et al. Proc. Natl. Acad. Sci. USA 88 (1991) 10065 Density averaging based on noncrystallographic 222 sym- A metry within the molecular envelope and solvent flattening outside followed by stepwise phase extension from 3.3 A to 3.0 A were carried out next (the program was kindly provided by E. M. Westbrook, Argonne National Laboratory). A total of21,631 reflections having F > 2o(F) in the resolution range 40.0 A-3.0 A (92% of possible data) were phased. The average phase shift, the map Rj,0~ and the final figure-of-merit were 79.60, 0.299, and 0.81, respectively. Fig. 1 shows the typical density for an a-helix of the symmetry-averaged final multiple isomorphous replacement (MIR) map. The model building was done on an Evans and Sutherland PS390 using FRODO (16). The chain tracing was B done for one subunit; the tetramer was generated by the 55 222-symmetry operation. The MIR model was refined with 45 noncrystallographic symmetry restraint by a version of the program PROLSQ (17) by using the CRAY Y-MP computer at 43 the Pittsburgh Supercomputing Center. The resolution was increased in steps to 2.6 A. The conventional R factor from the last cycle with 7424 protein atoms (255 residues and 1856 34~~~~~~~ atoms per subunit) and 176 NAD atoms is 0.231 for 26,753 (F > 2oF) reflections between 6.0 and 2.6 A resolution (R is l8 0.223 for 5.0-2.6 A). This represents 85% of possible data at 28 6.0-2.60 A (92% at 6.0-2.65 A). The rms deviations from ideality for various geometrical parameters are 0.025 A for the bond distance, 0.061 A for the angle distance, and 3.30 for the bond angle. The average rms deviation ofthe main-chain atoms offour subunits from the 222 symmetry is 0.28 A. The average individual temperature factorfor all atoms is 14.8 A2. No solvent (-50% ofthe cell volume is solvent) has yet been included in the model. The residue Asp-66 in the chemical sequence is tentatively Cys-66 in the present model; a Cys at this point is reconcilable with both the MIR and the calculated maps-the St atom of Cys-66 is at a distance of 2.6 ± 0.3 A from the refined Hg position of the isomorphous derivative. A Ramachandran plot of the refined structure shows that six nonglycine residues per subunit are in the disallowed regions; these belong to three loop areas and the carboxyl terminal, all of which have weak densities and very high temperature fac- FIG. 2. (A) Schematic diagram of the structure of 3a,20,(-HSD and the nomenclature of the secondary elements. (B) Stereographic view ofthe numbering ofresidues represented by their respective CO atoms. (C) Ribbon diagram of a subunit. The NAD(H) molecule is shown in pink and a cortisone molecule modeled in the apparent active site is shown in blue. Also shown in this diagram are some important residues: Met-94, Met-184, and Met-189 (yellow); Arg-16, Asp-37, and Lys-156 (blue); Tyr-152 and His-181 (red); and Thr-12, Ser-91, and Ser-139 (white).
Recommended publications
  • 1970Qureshiocr.Pdf (10.44Mb)
    STUDY INVOLVING METABOLISM OF 17-KETOSTEROIDS AND 17-HYDROXYCORTICOSTEROIDS OF HEALTHY YOUNG MEN DURING AMBULATION AND RECUMBENCY A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN NUTRITION IN THE GRADUATE DIVISION OF THE TEXAS WOI\IIAN 'S UNIVERSITY COLLEGE OF HOUSEHOLD ARTS AND SCIENCES BY SANOBER QURESHI I B .Sc. I M.S. DENTON I TEXAS MAY I 1970 ACKNOWLEDGMENTS The author wishes to express her sincere gratitude to those who assisted her with her research problem and with the preparation of this dissertation. To Dr. Pauline Beery Mack, Director of the Texas Woman's University Research Institute, for her invaluable assistance and gui­ dance during the author's entire graduate program, and for help in the preparation of this dissertation; To the National Aeronautics and Space Administration for their support of the research project of which the author's study is a part; To Dr. Elsa A. Dozier for directing the author's s tucly during 1969, and to Dr. Kathryn Montgomery beginning in early 1970, for serving as the immeclia te director of the author while she was working on the completion of the investic;ation and the preparation of this dis- sertation; To Dr. Jessie Bateman, Dean of the College of Household Arts and Sciences, for her assistance in all aspects of the author's graduate program; iii To Dr. Ralph Pyke and Mr. Walter Gilchrist 1 for their ass is­ tance and generous kindness while the author's research program was in progress; To Mr. Eugene Van Hooser 1 for help during various parts of her research program; To Dr.
    [Show full text]
  • The Effects of Exogenous ACTH on 5-3B-Hydroxysteroid Dehydrogenase Activity in the Embryonic Avian Adrenal Gland
    Loyola University Chicago Loyola eCommons Master's Theses Theses and Dissertations 1968 The Effects of Exogenous ACTH on 5-3b-hydroxysteroid Dehydrogenase Activity in the Embryonic Avian Adrenal Gland Grover Charles Ericson Loyola University Chicago Follow this and additional works at: https://ecommons.luc.edu/luc_theses Part of the Medicine and Health Sciences Commons Recommended Citation Ericson, Grover Charles, "The Effects of Exogenous ACTH on 5-3b-hydroxysteroid Dehydrogenase Activity in the Embryonic Avian Adrenal Gland" (1968). Master's Theses. 2264. https://ecommons.luc.edu/luc_theses/2264 This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in Master's Theses by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. Copyright © 1968 Grover Charles Ericson THE EFFECTS OF EXOGENOUS ACTH ON d -JB-HYDROXYSTEROID DEHYDROGENASE ACTIVITY IN THE EMBRYONIC AVIAN ADRENAL GLAND by Grover Charles Ericson A The.is Submitted to the Faculty ot the Graduate School of La.vo1. University in Partial Fulfillment ot the Requirements for the Degree ot Master ot Science February 1968 BIOGRAPHY Grover Charles Ericson was born in Oak Park, D.linois, on February 17. 1941. He •• graduated f'rom the Naperville COIIUlIW1ity High School, Naperville. D.l1nois in June, 19.59. He entered North Central College, Naperville. Illinois, in September, 19.59, and was awarded the Bachelor of Arts degree in June, 1964. While attending North Central College.
    [Show full text]
  • A Thesis Entitled "APPLICATIONS of GAS CHROMATOGRAPHY
    A Thesis entitled "APPLICATIONS OF GAS CHROMATOGRAPHY - MASS SPECTROMETRY IN STEROID CHEMISTRY" Submitted in part fulfilment of the requirements for admittance to the degree of Doctor of Philosophy in The University of Glasgow by T.A. Baillie, B.Sc. University of Glasgow 1973. ProQuest Number: 11017930 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 11017930 Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 ACKNOWLEDGEMENTS I would like to express my sincere thanks to Dr. C.3.W. Brooks for his guidance and encouragement at all times, and to Professors R.A. Raphael, F.R.S., and G.W. Kirby, for the opportunity to carry out this research. Thanks are also due to my many colleagues for useful discussions, and in particular to Dr. B.S. Middleditch who was associated with me in the work described in Section 3 of this thesis. The work was carried out during the tenure of an S.R.C. Research Studentship, which is gratefully acknowledged. Finally, I would like to thank Miss 3.H.
    [Show full text]
  • Structural Basis for Human Sterol Isomerase in Cholesterol Biosynthesis and Multidrug Recognition
    ARTICLE https://doi.org/10.1038/s41467-019-10279-w OPEN Structural basis for human sterol isomerase in cholesterol biosynthesis and multidrug recognition Tao Long 1, Abdirahman Hassan 1, Bonne M Thompson2, Jeffrey G McDonald1,2, Jiawei Wang3 & Xiaochun Li 1,4 3-β-hydroxysteroid-Δ8, Δ7-isomerase, known as Emopamil-Binding Protein (EBP), is an endoplasmic reticulum membrane protein involved in cholesterol biosynthesis, autophagy, 1234567890():,; oligodendrocyte formation. The mutation on EBP can cause Conradi-Hunermann syndrome, an inborn error. Interestingly, EBP binds an abundance of structurally diverse pharmacolo- gically active compounds, causing drug resistance. Here, we report two crystal structures of human EBP, one in complex with the anti-breast cancer drug tamoxifen and the other in complex with the cholesterol biosynthesis inhibitor U18666A. EBP adopts an unreported fold involving five transmembrane-helices (TMs) that creates a membrane cavity presenting a pharmacological binding site that accommodates multiple different ligands. The compounds exploit their positively-charged amine group to mimic the carbocationic sterol intermediate. Mutagenesis studies on specific residues abolish the isomerase activity and decrease the multidrug binding capacity. This work reveals the catalytic mechanism of EBP-mediated isomerization in cholesterol biosynthesis and how this protein may act as a multi-drug binder. 1 Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. 2 Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. 3 State Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China. 4 Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
    [Show full text]
  • Evolution of 17Beta-Hydroxysteroid Dehydrogenases and Their Role in Androgen, Estrogen and Retinoid Action
    UC San Diego UC San Diego Previously Published Works Title Evolution of 17beta-Hydroxysteroid Dehydrogenases and Their Role in Androgen, Estrogen and Retinoid Action Permalink https://escholarship.org/uc/item/1md640v5 Journal Molecular and Cellular Endocrinology, 171 Author Baker, Michael E Publication Date 2001 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Molec ular and Cellular Endocrinol ogy vol. 171, pp. 211 -215, 2001. Evolution of 17 -Hydroxysteroid Dehydrogenases and Their Role in Androgen, Estrogen and Retinoid Action Michael E. Baker Department of Medicine, 0823 University of California, San Diego 950 0 Gilman Drive La Jolla, CA 92093 -0823 phone: 858 -534 -8317 fax: 858 -822 -0873 e-mail: [email protected] Abstract. 17 -hydroxysteroid dehydrogenases (17 -HSDs) regulate androgen and estrogen concentrations in mammals. By 1995, four distinct enzymes with 17 -HSD activity had been identified: 17 -HSD -types 1 and 3, which in vivo are NADPH -dependent reductases; 17 -HSD - types 2 and 4, which in vivo are NAD +-dependent oxidases. Since then six additional enzymes with 17 -HSD activity have been isolated from mammal s. With the exception of 17 -HSD –type 5, which belongs to the aldoketo -reductase (AKR) family, these 17 -HSDs belong to the short chain dehydrogenases/reductases (SDR) family. Several 17 -HSDs appear to be examples of convergent evolution. That is, 17 -HSD activity arose several times from different ancestors. Some 17 -HSDs share a common ancestor with retinoid oxido -reductases and have retinol dehydrogenase activity. 17 -HSD -types 2, 6 and 9 appear to have diverged from ancestral retinoid dehydrogenas es early in the evolution of deuterostomes during the Cambrian, about 540 million years ago.
    [Show full text]
  • Nomenclature of Steroids
    Pure&App/. Chern.,Vol. 61, No. 10, pp. 1783-1822,1989. Printed in Great Britain. @ 1989 IUPAC INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY and INTERNATIONAL UNION OF BIOCHEMISTRY JOINT COMMISSION ON BIOCHEMICAL NOMENCLATURE* NOMENCLATURE OF STEROIDS (Recommendations 1989) Prepared for publication by G. P. MOSS Queen Mary College, Mile End Road, London El 4NS, UK *Membership of the Commission (JCBN) during 1987-89 is as follows: Chairman: J. F. G. Vliegenthart (Netherlands); Secretary: A. Cornish-Bowden (UK); Members: J. R. Bull (RSA); M. A. Chester (Sweden); C. LiCbecq (Belgium, representing the IUB Committee of Editors of Biochemical Journals); J. Reedijk (Netherlands); P. Venetianer (Hungary); Associate Members: G. P. Moss (UK); J. C. Rigg (Netherlands). Additional contributors to the formulation of these recommendations: Nomenclature Committee of ZUB(NC-ZUB) (those additional to JCBN): H. Bielka (GDR); C. R. Cantor (USA); H. B. F. Dixon (UK); P. Karlson (FRG); K. L. Loening (USA); W. Saenger (FRG); N. Sharon (Israel); E. J. van Lenten (USA); S. F. Velick (USA); E. C. Webb (Australia). Membership of Expert Panel: P. Karlson (FRG, Convener); J. R. Bull (RSA); K. Engel (FRG); J. Fried (USA); H. W. Kircher (USA); K. L. Loening (USA); G. P. Moss (UK); G. Popjiik (USA); M. R. Uskokovic (USA). Correspondence on these recommendations should be addressed to Dr. G. P. Moss at the above address or to any member of the Commission. Republication of this report is permitted without the need for formal IUPAC permission on condition that an acknowledgement, with full reference together with IUPAC copyright symbol (01989 IUPAC), is printed.
    [Show full text]
  • Comparative Proteomic Study Reveals 17Β-HSD13 As a Pathogenic Protein in Nonalcoholic Fatty Liver Disease
    Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease Wen Sua,1, Yang Wangb,c,1, Xiao Jiaa,1, Wenhan Wud, Linghai Lib, Xiaodong Tiand, Sha Lia, Chunjiong Wanga, Huamin Xua, Jiaqi Caoa, Qifei Hana, Shimeng Xub,c, Yong Chenb, Yanfeng Zhonge,f, Xiaoyan Zhangg, Pingsheng Liub,2, Jan-Åke Gustafssonh,2, and Youfei Guana,g,2 aDepartment of Physiology and Pathophysiology, Key Laboratory of Molecular Cardiovascular Science, Peking University Health Science Center, Beijing, 100191, China; bNational Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China; cUniversity of Chinese Academy of Sciences, Beijing, 100049, China; dDepartment of Surgery, Peking University First Hospital, Beijing, 100044, China; fDepartment of Pathology, Health Science Center and eBeijing Autopsy Center, Peking University, Beijing, 100191, China; gDepartment of Physiology, Shenzhen University Health Science Center, Shenzhen, 518060, China; and hCenter for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX 77204 Contributed by Jan-Åke Gustafsson, June 9, 2014 (sent for review May 24, 2014; reviewed by Yu Huang, Xiong Ruan, and Tianxin Yang) Nonalcoholic fatty liver disease (NAFLD) is characterized by a massive atherosclerosis. In addition to a monolayer of phospholipids, accumulation of lipid droplets (LDs). The aim of this study was to LDs are also covered by many proteins (12), which have been determine the function of 17β-hydroxysteroid dehydrogenase-13 considered to play an important role in the dynamic regulation of (17β-HSD13), one of our newly identified LD-associated proteins in the size and lipid contents of LDs (13). human subjects with normal liver histology and simple steatosis, in The hallmark feature of the pathogenesis of NAFLD is the NAFLD development.
    [Show full text]
  • Compounds of Natural Origin and Acupuncture for the Treatment of Diseases Caused by Estrogen Deficiency Abhishek Thakur 1, Subhash C
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector J Acupunct Meridian Stud 2016;9(3):109e117 Available online at www.sciencedirect.com Journal of Acupuncture and Meridian Studies journal homepage: www.jams-kpi.com REVIEW ARTICLE Compounds of Natural Origin and Acupuncture for the Treatment of Diseases Caused by Estrogen Deficiency Abhishek Thakur 1, Subhash C. Mandal 2, Sugato Banerjee 1,* 1 Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India 2 Division of Pharmacognosy, Pharmacognosy and Phytotherapy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India Available online 17 February 2016 Received: Sep 2, 2015 Abstract Revised: Jan 24, 2016 A predominant number of diseases affecting women are related to female hormones. In Accepted: Jan 28, 2016 most of the cases, these diseases are reported to be associated with menstrual problems. These diseases affect female reproductive organs such as the breast, uterus, and ovaries. KEYWORDS Estrogen is the main hormone responsible for the menstrual cycle, so irregular menstru- acupuncture; ation is primarily due to a disturbance in estrogen levels. Estrogen imbalance leads to estrogen; various pathological conditions in premenopausal women, such as endometriosis, breast natural compounds cancer, colorectal cancer, prostate cancer, poly cysts, intrahepatic cholestasis of preg- nancy, osteoporosis, cardiovascular diseases, obesity, etc. In this review, we discuss com- mon drug targets and therapeutic strategies, including acupuncture and compounds of natural origin, for the treatment of diseases caused by estrogen deficiency. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any me- dium, provided the original work is properly cited.
    [Show full text]
  • Physiological and Biochemical Aspects of 17Β-Hydroxysteroid Dehydrogenase Type 2 and 3
    Physiological and Biochemical Aspects of 17β-Hydroxysteroid Dehydrogenase Type 2 and 3 Inauguraldissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel von Roger Thomas Engeli aus Sulgen (TG), Schweiz Basel, 2017 Originaldokument gespeichert auf dem Dokumentenserver der Universität Basel edoc.unibas.ch Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung-Nicht kommerziell 4.0 International Lizenz. Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von Prof. Dr. Alex Odermatt und Prof. Dr. Rik Eggen Basel, den 20.06.2017 ________________________ Dekan Prof. Dr. Martin Spiess 2 Table of Contents Table of Contents ............................................................................................................................... 3 Abbreviations ..................................................................................................................................... 4 1. Summary ........................................................................................................................................ 6 2. Introduction ................................................................................................................................... 8 2.1 Steroid Hormones ............................................................................................................................... 8 2.2 Human Steroidogenesis....................................................................................................................
    [Show full text]
  • Characterization of Steroid-17,20-Desmolase and 20Α- Hydroxysteroid Dehydrogenase from Clostridium Scindens
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 1989 CHARACTERIZATION OF STEROID-17,20-DESMOLASE AND 20α- HYDROXYSTEROID DEHYDROGENASE FROM CLOSTRIDIUM SCINDENS Amy Elizabeth Krafft Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Microbiology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/4980 This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. School of Basic Health Sciences Virginia Commonwealth University This is to certify that the thesis or dissertation prepared by Amy Elizabeth Krafft entitled "The Characterization of steroid-17,20-Desmolase and 20«­ Hydroxysteroid Dehydrogenase from Clostridium scindens" has been approved by her committee as satisfactory completion of the thesis or dissertation requirement for the degree of Doctor of Philosophy. CHARACTERIZATION OF STEROID-17,20-DESMOLASE AND 20a-HYDROTfSTEROID DEfffDROGENASE FROM CLOSTRIDITJM SCINDENS A thesis submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University By Amy Elizabeth Krafft B.S., Mary Washington College, 1977 Director: Dr. Phillip B. Hylemon, Professor, Department of Microbiology and Immunology Virginia Commonwealth University Richmond, Virginia May, 1989 ii Acknowledgements I wish to thank Dr . Phillip Hylemon for all of the support he has given me during my graduate training. I also would like to thank my committee members for their guidance: Drs . Francis Macrina, Darrell Peterson, Thomas Huff, and Charles Schwartz .
    [Show full text]
  • Ágnes Berényi Anticancer Effects of Estrone Derivatives And
    University of Szeged Doctoral School of Pharmaceutical Sciences Pharmacology, Biopharmacy and Clinical Therapy Ph.D program Program leader: George Falkay Ph.D., D.Sc. Department of Pharmacodynamics and Biopharmacy Supervisor: Dr. habil. István Zupkó Ph.D. Ágnes Berényi Anticancer effects of estrone derivatives and nonsteroidal 17β- hydroxysteroid dehydrogenase type 1 inhibitors Exam board: Chairman: George Falkay Ph.D., D.Sc. Members: Zoltán Havass Ph.D. Ágnes Végh Ph.D., D.Sc. Reviewer broad: Chairman: Imre Máthé Ph.D., D.Sc. Reviewers: József Molnár Ph.D., D.Sc. Pál Perjési Ph.D. Member: Géza Regdon Ph.D. Secretary: Zsolt Szakonyi Ph.D. INTRODUCTION Cancer is a major health problem and leading disease in many countries worldwide. Accordance to the survey lung cancer is the leading cancer type of men’s while breast cancer of women’s. Growth control of the tumors is a very complex multifactorial process and characterized with dedifferentiation and uncontrolled cellular proliferation. Natural steroid products and their synthetic analogs are intensively investigated in order to describe and exploit their anticancer capacity, thus it could be considered a basic source of innovative drugs. Therefore, steroidal-type structures with different function group may suggest starting structures for novel synthetic antiproliferative drugs. Diosgenin and many related steroidal alkaloids exhibit potent anticancer effects. The most intensively investigated estrane is an endogenous estradiol metabolite, 2-methoxyestradiol, which does not exhibit hormonal activity, but seems to be highly effective against a broad range of cancer cell lines. The most important estrogen, 17β-estradiol, is involved in many hormone-dependent proliferative disorders in humans, including cancers of gynecological origin and endometriosis.
    [Show full text]
  • Estradiol RenE Maltais, Diana Ayan, and Donald Poirier*
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central LETTER pubs.acs.org/acsmedchemlett Crucial Role of 3-Bromoethyl in Removing the Estrogenic Activity of 17β-HSD1 Inhibitor 16β-(m-Carbamoylbenzyl)estradiol Rene Maltais, Diana Ayan, and Donald Poirier* Laboratory of Medicinal Chemistry, Endocrinology and Genomic Unit, CHUQ (CHUL) À Research Center and Laval University, Quebec (Quebec) G1V 4G2, Canada bS Supporting Information ABSTRACT: 17β-Hydroxysteroid dehydrogenase type 1 (17 β-HSD1) represents a promising therapeutic target for breast cancer treatment. To reduce the undesirable estrogenic activity of potent 17β-HSD1 inhibitor 16β-(m-carbamoylbenzyl)- estradiol (1) (IC50 = 27 nM), a series of analogues with a small functionalized side chain at position 3 were synthesized and tested. The 3-(2-bromoethyl)-16β-(m-carbamoylbenzyl)-estra- 1,3,5(10)-trien-17β-ol (5) was found to be a potent inhibitor (IC50 = 68 nM) for the transformation of estrone (E1) into estradiol (E2) and, most importantly, did not stimulate the proliferation of estrogen-sensitive MCF-7 cells, suggesting no estrogenic activity. From these results, the crucial role of a bromoalkyl side chain at carbon 3 was identified for the first time. Thus, this new inhibitor represents a good candidate with an interesting profile suitable for further studies including pharmacokinetic and in vivo studies. KEYWORDS: Steroid, estrogen, hormone, enzyme inhibitor, 17β-hydroxysteroid dehydrogenase, cancer ydroxysteroid dehydrogenase type
    [Show full text]